ZIOP : Summary for ZIOPHARM Oncology Inc - Yahoo Finance

U.S. Markets close in 5 hrs 11 mins

ZIOPHARM Oncology, Inc. (ZIOP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.09-0.12 (-1.98%)
As of 10:48AM EST. Market open.
People also watch
XONHALOCLDXJUNOKITE
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close6.21
Open6.18
Bid6.14 x 600
Ask6.15 x 200
Day's Range6.07 - 6.31
52 Week Range4.45 - 9.74
Volume524,790
Avg. Volume1,689,681
Market Cap794.13M
Beta1.93
PE Ratio (TTM)-4.60
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017
    Capital Cube2 days ago

    ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017

    Categories: Yahoo Finance Get free summary analysis ZIOPHARM Oncology, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ZIOPHARM Oncology, Inc. – Amgen Inc., Bristol-Myers Squibb Company, Nutraceutical International Corporation and Baxter International Inc. (AMGN-US, BMY-US, NUTR-US and BAX-US) that have also reported for this period. ... Read more (Read more...)

  • Investopedia7 days ago

    Ziopharm 4Q Loss 11 Cents a Share Vs 7c Last Year

    Ziopharm's fourth quarter loss was in line with analyst estimates.

  • Associated Press8 days ago

    Ziopharm reports 4Q loss

    On a per-share basis, the Boston-based company said it had a loss of 11 cents. The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...